A 64-year-old farmer notices a pearly, slowly enlarging nodule on his left lower lid margin with a central crust that bleeds when he rubs it. It has grown over eighteen months. He assumed it was a stubborn stye.
Examination Findings
Left lower lid margin shows a 7 mm pearly nodule with rolled edges, central ulceration and telangiectasia — classic for basal cell carcinoma. There is early madarosis (lash loss) at the site. No orbital involvement, lymph nodes normal, vision unaffected. The lesion involves the lid margin, which complicates reconstruction.
Investigations
Incisional or excisional biopsy with histopathology confirms basal cell carcinoma and its subtype (morpheic/infiltrative types need wider control). Clinical mapping documents the lesion’s extent including lid-margin involvement. Assessment for orbital invasion (motility, globe position) is done when lesions are large or medial. Photography records the baseline for reconstruction planning.
Questions to Think About
- Which clinical features should make any “stye” suspicious for malignancy?
- Why is lid-margin involvement a reconstructive challenge?
- What are the principles of tumour clearance plus lid reconstruction?
Diagnosis
Basal cell carcinoma of the left lower lid margin (biopsy-confirmed).
Reasoning
Reasoning: A pearly, ulcerated, telangiectatic lid-margin nodule growing over eighteen months with lash loss is basal cell carcinoma until biopsied otherwise. Complete excision with margin control (Mohs or frozen-section controlled excision) is the standard, and lid-margin defects need specialised reconstruction to restore both protection and appearance. Diagnosis: basal cell carcinoma of the left lower lid margin. Management: typical management is histologically controlled complete excision followed by lid reconstruction (direct closure for small defects; grafts or flaps for larger ones), with counselling that BCC rarely metastasises but recurs if incompletely excised. Follow-up watches for recurrence and new sun-related lesions, with sun-protection advice.
Differential Diagnosis
- Basal cell carcinoma — favoured: pearly rolled edges, telangiectasia, central ulceration, slow growth, lash loss.
- Chalazion — ruled out: eighteen months, ulceration, telangiectasia and madarosis are not chalazion features.
- Sebaceous carcinoma — considered: also malignant and lid-margin based, but the pearly rolled-edge morphology favours BCC; histology decides.
Management
Typical management includes complete excision with histologic margin control (Mohs micrographic surgery or frozen-section controlled excision where available), followed by oculoplastic reconstruction matched to defect size — direct closure, tarsoconjunctival grafts, or rotation flaps for larger margin defects. The patient is counselled on the excellent cure rate with complete excision, the need for surveillance for recurrence, and sun protection. Any orbital extension would escalate to multidisciplinary care.
Key Learning Points
- BCC clues: PEARLY rolled edges, TELANGIECTASIA, central ulceration, slow growth, LASH LOSS (madarosis).
- Any lid “stye” that persists, ulcerates, bleeds or loses lashes needs BIOPSY.
- Lid-margin tumours need tumour clearance PLUS specialised reconstruction — the lid must close and protect.
- BCC rarely spreads distantly but recurs locally if incompletely excised — margin control is the cure.
Red Flags
- A “stye” lasting months with ulceration, bleeding or lash loss — biopsy, don’t just incise.
- Incomplete excision of lid BCC — recurrence is disfiguring; margin control matters.
- Assuming benign because it is slow — BCC’s slow growth is exactly why it gets missed.
Educational content only — not medical advice. Clinical decisions must be made by a qualified professional for the individual patient.
Discuss this case with colleagues in the comments below.